Javascript must be enabled to continue!
Exploring the role of Nisha-amalaki in diabetes and its complications: Insights from Ayurveda and contemporary research
View through CrossRef
Nisha-amalaki, prepared from a combination formulation of turmeric (Nisha / Haridara / Curcuma longa) and Indian gooseberry (Amalaki/ Emblica officinalis), is proven in Ayurvedic knowledge and treatment for diabetes and its associated complications. Explore the study of Nisha-amalaki in glucose metabolism and glycaemic control instead of a pharmacological study. Nisha-amalaki is effective in controlling diabetes, Madhumeha, and Prameha. It has antioxidant, antihyperglycemic, insulinemia, antidiabetic, and alpha-glucosidase inhibitory properties. It improves sensitive insulin receptors and glucose uptake from muscle and is beneficial for diabetes management, along with controlling and preventing microvascular diabetes (diabetic retinopathy) and macrovascular diseases like atherosclerosis. Nisha-amalaki is a group of a combination of Haridara and amalaki called Nisha-amalaki. Nisha-amalaki is very effective in diabetic complications. This review emphasizes the colour, characters, potential and activity of Nisha-amalaki.
Title: Exploring the role of Nisha-amalaki in diabetes and its complications: Insights from Ayurveda and contemporary research
Description:
Nisha-amalaki, prepared from a combination formulation of turmeric (Nisha / Haridara / Curcuma longa) and Indian gooseberry (Amalaki/ Emblica officinalis), is proven in Ayurvedic knowledge and treatment for diabetes and its associated complications.
Explore the study of Nisha-amalaki in glucose metabolism and glycaemic control instead of a pharmacological study.
Nisha-amalaki is effective in controlling diabetes, Madhumeha, and Prameha.
It has antioxidant, antihyperglycemic, insulinemia, antidiabetic, and alpha-glucosidase inhibitory properties.
It improves sensitive insulin receptors and glucose uptake from muscle and is beneficial for diabetes management, along with controlling and preventing microvascular diabetes (diabetic retinopathy) and macrovascular diseases like atherosclerosis.
Nisha-amalaki is a group of a combination of Haridara and amalaki called Nisha-amalaki.
Nisha-amalaki is very effective in diabetic complications.
This review emphasizes the colour, characters, potential and activity of Nisha-amalaki.
Related Results
EFFECT OF NISHA AMALAKI YOGA ON GLYCEMIC CONTROL IN MADHUME-HA (TYPE 2 DIABETES MELLITUS)
EFFECT OF NISHA AMALAKI YOGA ON GLYCEMIC CONTROL IN MADHUME-HA (TYPE 2 DIABETES MELLITUS)
Background: Madhumeha is one of the types of Prameha as described in Ayurvedic texts, but it is closely similar to Type 2 Diabetes Mellitus (T2DM) in terms of aetiology, pathogenes...
Comparative Phytochemical and HPTLC Analysis of Nisha (Curcuma Longa Linn.) Chunra (powder), Amalaki (Phyllanthus emblica Linn.) Churna (Powder), and Nisha Amalaki Churna (Powder)
Comparative Phytochemical and HPTLC Analysis of Nisha (Curcuma Longa Linn.) Chunra (powder), Amalaki (Phyllanthus emblica Linn.) Churna (Powder), and Nisha Amalaki Churna (Powder)
Aim:
The aim of this study was to evaluate phytochemical constituent and high-performance thin-layer chromatography (HPTLC) analysis of Nisha churna, Amalaki churna, an...
619. Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses to Support Epetraborole Dose Selection for the Treatment of Patients with Mycobacterium avium Complex (MAC) Lung Disease
619. Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses to Support Epetraborole Dose Selection for the Treatment of Patients with Mycobacterium avium Complex (MAC) Lung Disease
Abstract
Background
Epetraborole (EBO) is an orally available, bacterial leucyl transfer RNA synthetase inhibitor that concentra...
LB2306. Population Pharmacokinetic (PPK), Pharmacokinetic/Pharmacodynamic attainment (PTA), and Clinical Pharmacokinetic/Pharmacodynamic (PK/PD) Analyses for Sulbactam-Durlobactam (SUL-DUR) to Support Dose Selection for the Treatment of Acinetobacter baum
LB2306. Population Pharmacokinetic (PPK), Pharmacokinetic/Pharmacodynamic attainment (PTA), and Clinical Pharmacokinetic/Pharmacodynamic (PK/PD) Analyses for Sulbactam-Durlobactam (SUL-DUR) to Support Dose Selection for the Treatment of Acinetobacter baum
Abstract
Background
SUL-DUR is a β-lactam/β-lactamase inhibitor combination in development for the treatment of ABC infections, ...
Cometary Physics Laboratory: spectrophotometric experiments
Cometary Physics Laboratory: spectrophotometric experiments
<p><strong><span dir="ltr" role="presentation">1. Introduction</span></strong&...
Nephroprotective effect of the combination of Nisha and Amalaki in Alloxan-induced hyperglycaemic rats
Nephroprotective effect of the combination of Nisha and Amalaki in Alloxan-induced hyperglycaemic rats
Background: Experimental studies have shown that Nisha (Curcuma longa L) rhizomes and Amalaki (Phyllanthus emblica L) fruits possess antidiabetic, antioxidant and nephroprotective ...
Undiagnosed Diabetes in Acute Coronary Syndrome: A Silent Threat in Pakistan
Undiagnosed Diabetes in Acute Coronary Syndrome: A Silent Threat in Pakistan
Diabetes mellitus (DM) has emerged as one of the most pressing public health challenges globally, and Pakistan stands among the countries most severely affected. With rising urbani...
In Vitro Antioxidant study of Amalaki (Emblica officinalis)
In Vitro Antioxidant study of Amalaki (Emblica officinalis)
Background: Amalaki (Emblica officinalis) which is used to cure a number of ailments & considered as Amrutphala (life giving fruit). Amalaki is best potent herb rich with antio...

